Scientists have shown for the first time that tumour DNA shed into the bloodstream can be used to track cancers in real time as they evolve and respond to treatment, according to a new Cancer Research UK study published in the journal Nature Communications.
Over three years, researchers at the University of Cambridge took surgical tumour samples (biopsies) and blood samples from a patient with breast cancer that had already spread to other parts of her body. They carefully studied small fragments of DNA from dying tumour cells that are shed into the blood, comparing them with DNA from the biopsy that was taken at the same point in time.
The results show that the DNA in the blood samples matched up with that from the biopsies, reflecting the same pattern and timing of genetic changes appearing as the cancer developed and responded to treatment. The results provide the first proof-of-principle that analysing tumour DNA in the blood can accurately monitor cancer within the body.
Study author Professor Carlos Caldas, senior group leader at the Cancer Research UK Cambridge Institute, said: “This definitively shows that we can use blood-based DNA tests to track the progress of cancer in real time. The findings could change the way we monitor patients, and may be especially important for people with cancers that are difficult to reach, as taking a biopsy can sometimes be quite an invasive procedure.”
The patient in the study had breast cancer that had already spread to a number of other organs. The researchers – part of a collaborative team effort involving the Carlos Caldas and Nitzan Rozenfeld laboratories at the Cancer Research UK Cambridge Institute – were even able to distinguish between the different secondary cancers and examine how each of the tumours was responding to treatment.
Professor Caldas added: “We were able to use the blood tests to map out the disease as it progressed. We now need to see if this works in more patients and other cancer types, but this is an exciting first step.”
The Latest on: Track cancer development
via Google News
The Latest on: Track cancer development
- 2 Small-Cap Biotech IPOs You Should Know Abouton July 18, 2019 at 12:20 pm
better understand the mechanisms at play between the immune system and cancer cells, match patients with alternative treatments to improve outcomes, and bolster drug discovery efforts before hundreds ... […]
- A brighter future is possible with the launch of The Baker Centre for Pancreatic Canceron July 17, 2019 at 8:30 am
The centre will offer a multidisciplinary clinic, new diagnostic technology, streamlined process for patients and the development ... Pancreatic Cancer will develop a database to track and measure ... […]
- New method spots rare immune cells reactive against canceron July 16, 2019 at 7:12 am
The patented 'RAGE-seq' method enables scientists to track how immune cells evolve ... Immune cells play a critical role in the development of disease. This method shows significant potential to help ... […]
- United States Non-Melanoma Skin Cancer Market Study 2019: Analyses & Forecasts Through 2014-2024 - ResearchAndMarkets.comon July 11, 2019 at 7:49 am
Research Scope Non-Melanoma Skin Cancer pipeline: Find out the products in clinical trials for the treatment of Non-Melanoma Skin Cancer by development phase 3 ... Cancer market analysis and sales ... […]
- Why Personalis Is Helping Make Cancer Therapy Personal For Each Patienton July 11, 2019 at 7:24 am
I had missed out on the golden opportunity for investing in the phenomenally successful new method for treating cancer in humans. However, with the growing track record for the efficacy using ... […]
- Cancer Profiling Market Analysis, Trend, and Competitive Market Share and Forecast by 2025on July 11, 2019 at 5:31 am
Jul 11, 2019 (HTF Market Intelligence via COMTEX) -- AMA recently published a detailed study of over 180+ pages in its repository on 'Cancer Profiling' market covering interesting aspects of market ... […]
- Embarrassment putting Australian women at risk of cervical cancer, research findson July 10, 2019 at 6:52 pm
A study published last year in leading medical journal The Lancet found Australia was on track to become the first country in the world to effectively eliminate cervical cancer by 2035. Professor Ian ... […]
- Single Nucleotide Polymorphism Market Leading Manufacturers and Development Strategies Forecast 2024on July 9, 2019 at 11:51 pm
In common SNPs have no effect on health or development ... also helps to track the inheritance of disease genes within families. Many studies are going on identifying the association of SNPs with ... […]
- Cellectar Receives FDA Fast Track Designation for CLR 131 in Diffuse Large B-Cell Lymphomaon July 9, 2019 at 5:05 pm
development and commercialization of drugs for the treatment of cancer, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for CLR 131 in relapsed or ... […]
- Innovative Therapy Given Fast Track Designation for Diffuse Large B-Cell Lymphomaon July 9, 2019 at 7:40 am
targeted phospholipid drug conjugate that delivers cytotoxic radiation directly to cancer cells to help limit exposure to healthy cells. The FDA’s decision to give the therapy a Fast Track designation ... […]
via Bing News